Company Filing History:
1 out of 2,345 
1 out of 2,010 
Years Active: 2018
Title: The Innovative Contributions of Jillian Gunther
Introduction
Jillian Gunther is a prominent inventor based in Houston, TX (US). She has made significant strides in the field of cancer treatment through her innovative research and development of novel therapeutic agents. Her work focuses on addressing hormone-refractory cancers, which are notoriously difficult to treat.
Latest Patents
Jillian holds a patent for "Tetra-aryl cyclobutane inhibitors of androgen receptor action for the treatment of hormone refractory cancer." This patent presents tetra-substituted cyclobutane inhibitors that target androgen receptor action, providing new methods for treating hormone-refractory cancers. Her groundbreaking work in this area has the potential to improve treatment outcomes for patients facing these challenging conditions. She has 1 patent to her name.
Career Highlights
Throughout her career, Jillian has worked with esteemed institutions such as the University of Illinois and Duke University. Her experience in these prestigious organizations has allowed her to collaborate with leading experts in the field and contribute to significant advancements in cancer research.
Collaborations
Jillian has collaborated with notable colleagues, including John A. Katzenellenbogen and Donald P. McDonnell. These partnerships have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Jillian Gunther's contributions to cancer treatment through her innovative inventions and collaborations highlight her dedication to advancing medical science. Her work continues to inspire future research and development in the field of oncology.